Physician profile
Adel Barkat
NPI 1467776476
$458,567.39
in general payments reported to CMS, 2019-2025
49 companies · $116K in 2025
The $116K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $13K · 2021: $67K · 2022: $57K · 2023: $73K · 2024: $116K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117K · Travel and Lodging: $72K · Consulting Fee: $51K · Food and Beverage: $40K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $25K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116,675.00 |
| Travel and Lodging | $72,238.75 |
| Consulting Fee | $51,437.50 |
| Food and Beverage | $39,810.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $25,075.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $178,637.13 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Silk Road Medical, INC. | $170,110.89 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $26,804.95 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $21,184.62 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Eluvia, General - Vascular Intervention |
| Medtronic, INC. | $16,015.05 | 2021-2025 | Endurant Iis, Valiant Captivia, Hawkone |
| Abiomed | $7,112.97 | 2019-2025 | Impella |
| Endologix LLC | $6,721.30 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $5,735.42 | 2019-2020 | |
| Angiodynamics, INC. | $4,491.46 | 2019-2025 | Angiovac, Alphavac, Micro Access |
| Inari Medical, INC. | $4,433.58 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Limflow System |
| Bolton Medical INC | $3,287.69 | 2020-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| W. L. Gore & Associates, INC. | $2,311.55 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $2,086.39 | 2019-2025 | Zenith Alpha, Zilver Ptx |
| Abbott Laboratories | $1,486.94 | 2022-2025 | Esprit, Supera, Xact |
| Centerline Biomedical INC. | $1,116.58 | 2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $910.59 | 2021-2025 | Floseal, Preveleak, Tisseel |
| Janssen Pharmaceuticals, INC | $887.29 | 2019-2023 | Xarelto |
| Cook Incorporated | $866.20 | 2023 | Zenith Alpha |
| Imperative Care, INC | $736.67 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Bard Peripheral Vascular, INC. | $648.72 | 2019-2024 | Venclose Maven Catheter |
| Asahi Intecc USA, INC. | $289.11 | 2023 | Asahi Ptca Guide Wire |
| Cvrx, INC. | $270.04 | 2021-2025 | Barostim Neo System |
| Reflow Medical INC | $257.03 | 2025 | |
| Edwards Lifesciences Corporation | $229.87 | 2021-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Nalu Medical, INC. | $223.97 | 2025 | Nalu Neurostimulation System |
| Surmodics, INC. | $220.04 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Artivion, INC. | $199.78 | 2019 | |
| Stryker Corporation | $194.00 | 2023-2025 | 1688, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shape Memory Medical INC. | $181.27 | 2025 | Impede Embolization Plug |
| Elutia, INC. | $170.63 | 2019 | |
| Davol INC. | $156.08 | 2021-2023 | Tridyne Vascular Sealant |
| Atricure, INC. | $130.69 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| E.R. Squibb & Sons, L.L.C. | $119.53 | 2019-2025 | Eliquis |
| Cardiva Medical, INC. | $48.83 | 2022 | |
| Kerecis Limited | $28.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Chiesi USA, INC. | $26.85 | 2021-2023 | Kengreal, Cleviprex |
| Depuy Synthes Sales INC. | $25.69 | 2019 | |
| Acera Surgical, INC. | $24.86 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $21.70 | 2022 | |
| Alphatec Spine, INC | $20.58 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $18.37 | 2023 | Andexxa |
| Lemaitre Vascular, INC. | $18.02 | 2023 | Artegraft Vascular Graft |
| Hologic Sales and Service, LLC | $17.40 | 2023 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $16.72 | 2024 | |
| Cordis US Corp. | $15.66 | 2023 | Mynxgrip |
| Organogenesis INC. | $15.17 | 2022 | |
| Getinge USA Sales, LLC | $14.36 | 2020 | |
| Solventum Corporation | $13.92 | 2024 | Prevena, V.A.C. Veraflo |
| Novartis Pharmaceuticals Corporation | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Barkat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.